source
- Lilly adds $4.5 billion to Indiana manufacturing to boost weight-loss drug supplyEli Lilly & Co. announced an additional $4.5 billion investment in two of its three manufacturing sites in Lebanon, Indiana. The funding is aimed at expanding capacity for both its genetic therapie…
- Former FDA officials and pharma groups weigh in as Supreme Court considers mifepristone regulationThe Supreme Court is expected to act on a case involving the abortion pill mifepristone after a pause on a federal appeals court order that halted mail‑order distribution. The decision could resha…